Clinical Trial Update: Effect of Influenza Vaccination on Global Systemic Inflammatory Markers in Patients With Stable Coronary Artery Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed to assess whether influenza vaccination alters global systemic inflammatory markers in patients with stable coronary artery dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: University Hospital, Tours | Conditions: Coronary Artery Disease, Inflammatory Response | Phase 4 | Status: COMPLETED